@Claris_Lifesciences is planning to sell its injectibles business and it is in preliminary talks with Japanese Pharma firm - Otsuka Pharma for the same.
IDFC and Barclays are the bankers to the deal, ET stated.
This news comes after the announcement by Strides Arcolabs to put up its injectable-drugs unit, @Agila_Specialties Private Limited for sale.
Ahmedabad based, Claris Lifesciences offers injectibles in various therapeutic segments including anesthesia, critical care, anti-infectives, renal care, infusion therapy, parenteral nutrition and oncology.
It has presence in 91 countries across Latin America, Europe, Gulf, Africa, CIS, Central Asia and Asia- Pacific. Last month, Mitsui of Japan, through its healthcare arm, was plnning to invest R250 Cr in Claris.